Gane E. Safety and Efficacy at 1 year after Switching from Tenofovir Disoproxil Fumurate to Tenofovir Alafenamide in Chronic HBV Patients with Risk Factors for TDF Use. PS-156.
Nijmeegse spin-off zoekt met AI nieuwe mugwerende middelen
sep 2021 | Parasitaire infecties, Virale infecties